EA202192344A1 - Тритерпеноидные фунгициды для лечения или предотвращения пневмоцистной пневмонии, вызванной pneumocystis spp - Google Patents

Тритерпеноидные фунгициды для лечения или предотвращения пневмоцистной пневмонии, вызванной pneumocystis spp

Info

Publication number
EA202192344A1
EA202192344A1 EA202192344A EA202192344A EA202192344A1 EA 202192344 A1 EA202192344 A1 EA 202192344A1 EA 202192344 A EA202192344 A EA 202192344A EA 202192344 A EA202192344 A EA 202192344A EA 202192344 A1 EA202192344 A1 EA 202192344A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
triterpenoid
pneumocystis spp
pneumocystispneumonia
Prior art date
Application number
EA202192344A
Other languages
English (en)
Russian (ru)
Inventor
Давид А. Ангуло Гонсалес
Стефен Эндрю Барат
Original Assignee
Сайнексис, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сайнексис, Инк. filed Critical Сайнексис, Инк.
Publication of EA202192344A1 publication Critical patent/EA202192344A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
EA202192344A 2019-02-27 2020-02-25 Тритерпеноидные фунгициды для лечения или предотвращения пневмоцистной пневмонии, вызванной pneumocystis spp EA202192344A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962811456P 2019-02-27 2019-02-27
PCT/US2020/019724 WO2020176527A1 (en) 2019-02-27 2020-02-25 Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia

Publications (1)

Publication Number Publication Date
EA202192344A1 true EA202192344A1 (ru) 2021-11-15

Family

ID=70005768

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192344A EA202192344A1 (ru) 2019-02-27 2020-02-25 Тритерпеноидные фунгициды для лечения или предотвращения пневмоцистной пневмонии, вызванной pneumocystis spp

Country Status (15)

Country Link
US (1) US12594266B2 (cg-RX-API-DMAC7.html)
EP (1) EP3930716B1 (cg-RX-API-DMAC7.html)
JP (1) JP7581219B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210133241A (cg-RX-API-DMAC7.html)
CN (1) CN113631165A (cg-RX-API-DMAC7.html)
AU (1) AU2020228036B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021016876A2 (cg-RX-API-DMAC7.html)
CA (1) CA3131298A1 (cg-RX-API-DMAC7.html)
EA (1) EA202192344A1 (cg-RX-API-DMAC7.html)
ES (1) ES3055272T3 (cg-RX-API-DMAC7.html)
IL (1) IL285839A (cg-RX-API-DMAC7.html)
MA (1) MA55081A (cg-RX-API-DMAC7.html)
MX (2) MX2021010311A (cg-RX-API-DMAC7.html)
TW (1) TWI910099B (cg-RX-API-DMAC7.html)
WO (1) WO2020176527A1 (cg-RX-API-DMAC7.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
CN108883152A (zh) * 2016-01-08 2018-11-23 奇达拉治疗公司 防止和治疗肺孢子虫感染的方法
JP7263313B2 (ja) * 2017-04-10 2023-04-24 サイネクシス,インコーポレーテッド 併用される抗真菌剤
PL3661503T3 (pl) 2017-08-04 2023-01-09 Scynexis, Inc. Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph

Also Published As

Publication number Publication date
KR20210133241A (ko) 2021-11-05
JP7581219B2 (ja) 2024-11-12
US12594266B2 (en) 2026-04-07
EP3930716A1 (en) 2022-01-05
JP2022523212A (ja) 2022-04-21
MA55081A (fr) 2022-01-05
WO2020176527A1 (en) 2020-09-03
IL285839A (en) 2021-10-31
BR112021016876A2 (pt) 2021-11-03
MX2021010311A (es) 2022-01-04
AU2020228036B2 (en) 2025-08-07
AU2020228036A1 (en) 2021-09-23
ES3055272T3 (en) 2026-02-10
MX2025004197A (es) 2025-09-02
US20230149376A1 (en) 2023-05-18
CA3131298A1 (en) 2020-09-03
TW202045169A (zh) 2020-12-16
CN113631165A (zh) 2021-11-09
TWI910099B (zh) 2026-01-01
EP3930716B1 (en) 2025-09-10

Similar Documents

Publication Publication Date Title
SA522433000B1 (ar) مركبات فلورو ألكيل-أوكساديازول واستخداماتها
MX2022011804A (es) Uso de agentes para el tratamiento de condiciones respiratorias.
ECSP12012002A (es) Compuesto heterocíclico conteniendo nitrógeno y fungicida para el uso en agricultura y jardinería
EA201290451A1 (ru) Способ лечения фибрилляции предсердий
MX2023001756A (es) Peptidos funcionalizados como agentes antivirales.
MX2025005792A (es) Combinaciones farmaceuticas y usos de las mismas
NO20073774L (no) Terapeutiske forbindelser for intranasal administrering av ketorolac
MX2023012875A (es) Inhibidores 2-fluoro alquil-l,3,4-oxadiazol-5-il-tiazol de hdac6 para su uso en el tratamiento de enfermedades metabólicas y hfpef.
CO2022016153A2 (es) Inhibidores de il4i1 y métodos de uso
MX2023013225A (es) Inhibidores de la cinasa 4 similar a polo.
PH12023550780A1 (en) Line-1 inhibitors to treat disease
MX2022003845A (es) Tratamientos cognitivos medicinales.
MX2024002409A (es) Terapias contra el cancer.
MX2021011289A (es) Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas.
WO2019010301A8 (en) Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap)
MX2022012001A (es) Tratamiento preventivo de la migra?a.
MX2023014898A (es) Terapia combinada anti-vhc ventajosa.
EA202090445A1 (ru) ПРОТИВОГРИБКОВЫЕ СРЕДСТВА С ПОВЫШЕННОЙ АКТИВНОСТЬЮ ПРИ КИСЛОМ pH
WO2020101790A3 (en) Methods of using a phenoxypropylamine compound to treat pain
CL2021003303A1 (es) Tratamiento para sinucleinopatías.
JOP20210221A1 (ar) علاجات مشتركة لاستخدامها في علاج السرطان
MX2019012116A (es) Agentes antifungicos utilizados en combinacion.
MX2024014728A (es) Inhibidor de arginasa y composicion farmaceutica que comprende el mismo
Andersen et al. sGC–cGMP–PKG pathway stimulation protects the healthy but not the failing right ventricle of rats against ischemia and reperfusion injury
MX2021010311A (es) Antifúngicos triterpenoides para el tratamiento o prevención de neumonía por pneumocystis spp.